Concepedia

Publication | Open Access

Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–small-cell Lung Carcinoma

DOIFull Paper Access

22

Citations

33

References

2018

Year

Beth A. Hellerstedt, Nicholas J. Vogelzang, Harriet M. Kluger, Christopher A. Yasenchak, Dana T. Aftab, David A. Ramies, Michael S. Gordon, Primo Lara
Clinical Lung Cancer

References

YearCitations

Page 1